Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of Apr 17
 -2.04 / -0.98%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 222.00, with a high estimate of 243.00 and a low estimate of 170.00. The median estimate represents a +8.12% increase from the last price of 205.32.

Analyst Recommendations

The current consensus among 22 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.80%
Growthannually 26.42%


Growthquarterly -5.91%
Growthannually 21.15%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account